Cathay Biotech
68806545.511.13% ( -0.52 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Cathay Biotech(688065) the Revenue is 874.53 M (+12.73%);the EBIT is 213.41 M (+49.09%);the EPS is 0.23 (+0%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.87B12.73%
----
----
EBIT
0.21B49.09%
----
----
EPS
0.23--
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf